SCHEMBL19202802

SCHEMBL19202802

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c6ccccc6n(-c6ccc(-c7cc8c9c(cccc9c7)-c7ccccc7-8)cc6)c5c4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
ATM Q13315 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 4/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPK1 P28482 3/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
HIF1A Q16665 1/20 0.35
TSPO P30536 1/20 0.34
HDAC4 P56524 1/20 0.34
PTGER4 P35408 1/20 0.33
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
PDE6D O43924 1/20 0.31
ANPEP P15144 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19202801 1.00 L3MBTL1 (0.41) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL20466589 0.96 L3MBTL1 (0.44) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202699 0.96 L3MBTL1 (0.44) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202856 0.95 L3MBTL1 (0.45) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202804 0.95 L3MBTL1 (0.45) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202880 0.95 L3MBTL1 (0.38) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202881 0.95 L3MBTL1 (0.38) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202796 0.94 L3MBTL1 (0.40) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL19202719 0.94 L3MBTL1 (0.40) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL21855084 0.94 L3MBTL1 (0.40) L3MBTL1ATMKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312159-B1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO (JP) 2022-01-26 EP disclosed
US-10790449-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-09-29 US disclosed
US-20180226601-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, DISPLAY DEVICE, AND MIXED MATERIAL IDEMITSU KOSAN CO., LTD. (JP) 2018-08-09 US disclosed
US-20180226601-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, DISPLAY DEVICE, AND MIXED MATERIAL IDEMITSU KOSAN CO., LTD. (JP) 2018-08-09 US disclosed
EP-3312159-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2018-04-25 EP disclosed
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-03 US disclosed
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10790449-B2 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device RPL19, LEF1, RPL39 L3MBTL1 174/4885ATM 2630/4885KDM4E 838/4885
US-20170222152-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE RPL19, LEF1, RPL39 L3MBTL1 174/4885ATM 2630/4885KDM4E 838/4885
US-20180226601-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATION DEVICE, DISPLAY DEVICE, AND MIXED MATERIAL TMEM109, L1CAM, CD99 L3MBTL1 1896/4885ATM 1768/4885KDM4E 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.